New treatment strategy
Researchers at Johns Hopkins report they have identified a protein that enables a toxic natural aggregate to spread from cell to cell in a mammal’s brain — and a way…
Read article
Research news
Vaccine for Parkinson’s Reports Positive Results
The Michael J Fox Foundation reports that new study results from Austrian biotech AFFiRiS support continued development of its vaccine against the key Parkinson’s protein alpha-synuclein. Today the company announced…
A Biomarker for Parkinson’s
The Scotsman newspaper reports today (29 August, 23016) that scientists are a step closer to developing a test for early-stage Parkinson’s. Research has shown that a molecule linked to the…
New finding about alpha synuclein
Science Today reports that researchers at the University of Pittsburgh School of Medicine have uncovered a major reason why the Parkinson’s-related protein alpha-synuclein, a major constituent of the Lewy bodies…
Transplanted Nerve Cells Survive for 25 Years
In the late 1980s and over the 1990s, researchers at Lund University in Sweden pioneered the transplantation of new nerve cells into the brains of patients with Parkinson’s disease. The…
FDA approves new Parkinson’s psychosis drug
The Michael J Fox Foundation (MJFF) reports today that Nuplazid has become the first medication approved for Parkinson’s psychosis (hallucinations and delusions). Previously available psychosis medications worked on both the…